These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2533896)

  • 21. Randomized, double-blind, dose-finding study of dexamethasone in preventing acute emesis induced by anthracyclines, carboplatin, or cyclophosphamide:
    Italian Group For Antiemetic Research
    J Clin Oncol; 2004 Feb; 22(4):725-9. PubMed ID: 14966097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical efficacy of GG032X tablets, a new dosage form of ondansetron (fast dispersing tablet), on cisplatin-induced nausea and emesis].
    Ariyoshi Y; Nukariya N; Akasaka Y; Suminaga M; Ota J; Ikeda M; Taguchi T
    Gan To Kagaku Ryoho; 1997 Jun; 24(8):995-1011. PubMed ID: 9212810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiemetic efficacy and pharmacokinetics of intravenous ondansetron infusion during chemotherapy conditioning for bone marrow transplant.
    Agura ED; Brown MC; Schaffer R; Donaldson G; Shen DD
    Bone Marrow Transplant; 1995 Aug; 16(2):213-22. PubMed ID: 7581139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Controlling conditioning-related emesis in children undergoing bone marrow transplantation.
    Mehta NH; Reed CM; Kuhlman C; Weinstein HJ; Parsons SK
    Oncol Nurs Forum; 1997 Oct; 24(9):1539-44. PubMed ID: 9348595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
    Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P
    J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer chemotherapy-induced nausea and vomiting: role of mediators, development of drugs and treatment methods.
    Mahesh R; Perumal RV; Pandi PV
    Pharmazie; 2005 Feb; 60(2):83-96. PubMed ID: 15739895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America.
    Poli-Bigelli S; Rodrigues-Pereira J; Carides AD; Julie Ma G; Eldridge K; Hipple A; Evans JK; Horgan KJ; Lawson F;
    Cancer; 2003 Jun; 97(12):3090-8. PubMed ID: 12784346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Escalating dose of oral ondansetron in the prevention of radiation induced emesis.
    Maisano R; Pergolizzi S; Settineri N
    Anticancer Res; 1998; 18(3B):2011-3. PubMed ID: 9677458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy of ondansetron in radiation-induced nausea and vomiting: review of the literature].
    Lévy E; Paillarse JM; Votan B
    Bull Cancer Radiother; 1994; 81(3):179-85. PubMed ID: 7702901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological and anti-emetic properties of ondansetron.
    Tyers MB; Bunce KT; Humphrey PP
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 1():S15-9. PubMed ID: 2533894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ondansetron. Therapeutic use as an antiemetic.
    Milne RJ; Heel RC
    Drugs; 1991 Apr; 41(4):574-95. PubMed ID: 1711961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the mechanism of radiation-induced emesis: the role of serotonin.
    Scarantino CW; Ornitz RD; Hoffman LG; Anderson RF
    Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):825-30. PubMed ID: 7525517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The final assessment of a randomized double-blind comparative study of ondansetron vs. metoclopramide in the prevention of nausea and vomiting following high-dose upper abdominal irradiation.
    Clin Oncol (R Coll Radiol); 1991 Jul; 3(4):241-2. PubMed ID: 1834162
    [No Abstract]   [Full Text] [Related]  

  • 34. Management of gastrointestinal complaints in differentiated thyroid cancer patients treated with (131)I: comparison of the efficacy of pantoprazole, metoclopramide, and ondansetron - a randomized clinical trial.
    Mirzababaee M; Shafiei B; Seifollahi S; Motazdian M; Fatholahi L; Delavari S; Naghshine R; Baharfar N; Tabeie F; Javadi H; Assadi M; Asli IN
    Nuklearmedizin; 2014; 53(5):186-9. PubMed ID: 24961816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy and safety of GR38032F in the prophylaxis of ifosfamide-induced nausea and vomiting.
    Green JA; Watkin SW; Hammond P; Griggs J; Challoner T
    Cancer Chemother Pharmacol; 1989; 24(2):137-9. PubMed ID: 2525078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ondansetron--a 5HT 3 receptor antagonist for the treatment of nausea and vomiting induced by cytostatics and radiotherapy].
    Herrstedt J; Ersbøll J; Dombernowsky P
    Ugeskr Laeger; 1991 Apr; 153(18):1292-5. PubMed ID: 1827555
    [No Abstract]   [Full Text] [Related]  

  • 37. [New, in Austria registered specialty drugs. Zofran (Ondansetron, Glaxo)].
    Erben M
    Wien Klin Wochenschr; 1991; 103(19):594-601. PubMed ID: 1836917
    [No Abstract]   [Full Text] [Related]  

  • 38. Ondansetron in the control of refractory emesis following radiotherapy.
    Roberts JT
    Clin Oncol (R Coll Radiol); 1992 Jan; 4(1):67-8. PubMed ID: 1531294
    [No Abstract]   [Full Text] [Related]  

  • 39. The clinical pharmacology of ondansetron.
    Blackwell CP; Harding SM
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 1():S21-4; discussion S25-7. PubMed ID: 2533895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of ondansetron on radiation-induced emesis and diarrhoea.
    Henriksson R; Lomberg H; Israelsson G; Zackrisson B; Franzén L
    Acta Oncol; 1992; 31(7):767-9. PubMed ID: 1476756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.